Rhythm Pharmaceuticals target price cut to $160 from $166
RYTM•Citizens cut its target price for Rhythm Pharmaceuticals to $160 from $166.
Related News

AI selloff drives Taiwan to worst week since 1990, rattles Asia markets
SMH•

Nasdaq trade halt continues, reason not available at 03:58 am
UCFI•

Coca-Cola FEMSA raises target price to $128 from $125
KOF•

HSBC files next day disclosure return to HKEX announcing share buyback and cancellation
HSBC•

UBS raises total voting rights in Renk to 5.2% from 4.71%
UBS•